Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

Something new under the skin

One-size-fits-all intravenous delivery of biologics may be giving way to alternate delivery routes that enable safer and more efficient drug administration. Michael Eisenstein reports.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout


  1. Cortelezzi, A. et al. Leukemia 23, 2027–2033 (2009).

    Article  CAS  Google Scholar 

  2. Stilgenbauer, S. et al. J. Clin. Oncol. 27, 3994–4001 (2009).

    Article  CAS  Google Scholar 

  3. Li, G. et al. Int. J. Pharm. 368, 109–115 (2009).

    Article  CAS  Google Scholar 

  4. Ottiger, M. et al. Invest. Ophthalmol. Vis. Sci. 50, 779–786 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Supplementary information

Supplementary Text and Figures

Supplementary Table (XLS 22 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eisenstein, M. Something new under the skin. Nat Biotechnol 29, 107–109 (2011).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research